ED
NEOG icon

Exane Derivatives’s Neogen NEOG Stock Holding History

Exane Derivatives’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$241 Sell
10
-2,831
-100% -$76K ﹤0.01% 657
2022
Q1 		$87.6K Sell
2,841
-575
-17% -$20.7K 0.02% 487
2021
Q4 		$155K Sell
3,416
-1,026
-23% -$43.9K 0.04% 387
2021
Q3 		$193K Sell
4,442
-733
-14% -$31.9K 0.05% 400
2021
Q2 		$234K Sell
5,175
-1,699
-25% -$78.5K 0.05% 357
2021
Q1 		$306K Sell
6,874
-2,884
-30% -$121K 0.09% 216
2020
Q4 		$387K Buy
+9,758
New +$363K 0.11% 211

Other funds holding NEOG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Exane Derivatives's NEOG Position: Q2 2022 in Review

Exane Derivatives reduced its Neogen (NEOG) stake by 100% in Q2 2022, selling an estimated $76K and leaving 10 shares worth $241. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Exane Derivatives first reported a position in NEOG in Q4 2020 and has held it in 7 quarters since. The position peaked at $387K in Q4 2020. 309 funds tracked by Wall St. Rank hold NEOG as of Q2 2022.

  • Exane Derivatives held 10 shares of Neogen worth $241 as of Q2 2022.
  • Exane Derivatives sold 2,831 Neogen shares in Q2 2022, an estimated $76K.
  • Neogen made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #657 holding.
  • Exane Derivatives first reported a position in Neogen in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Neogen position peaked at $387K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held Neogen as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.